Ocugen Inc

NASDAQ:OCGN   3:59:58 PM EDT
6.03
-0.31 (-4.89%)
Products

Ocugen Expands Covaxin™ Commercialization Rights To Include Canada

Published: 06/03/2021 11:43 GMT
Ocugen Inc (OCGN) - Ocugen Expands Covaxin™ Commercialization Rights to Include Canada.
Ocugen - to Have Exclusive Co-development, Manufacturing, and Commercialization Rights to Covaxin in Canada, in Addition to Its Existing US Rights.
Ocugen - Will Make Upfront Payment and Milestone Payment Upon First Commercial Sale in Canada to Bharat Biotech.
Ocugen Inc - Will Retain 45% of Profits From Sales of Covaxin(tm) in Canada.